Background Huntington's disease is caused by a CAG repeat expansion in the huntingtin
gene, HTT. Age at onset has been used as a quantitative phenotype in genetic analysis …

Background: Biomarkers are needed to monitor disease progression, target engagement
and efficacy in Huntington’s disease (HD). Cerebrospinal fluid (CSF) is an ideal medium to …

Huntington's disease (HD) is an inherited neurodegenerative disorder that is well recognised
as producing progressive deterioration of motor function, including dyskinetic movements, …

Background Although health-related quality of life is key for patients with long-term
neurodegenerative conditions, measuring this is less straightforward and complex in Huntington’s …

Abstracts Page 1 Methods/Techniques Five grandparents and five grandchildren belonging
to four families affected by HD participated in this study. A qualitative case study …

Abstracts Page 1 TRACK-HD/ON. A large, easy access Registry dataset (RDS) prepared in
a format similar to the Enroll-HD PDS can augment the Enroll-HD PDS and thereby increase …

The European Huntington’s Disease Network (EHDN), established in 2003, is a non-profit
research network with the mission of advancing research, facilitating conduct of clinical trials, …

The certification scheme aims to improve efficiency and expedite the site selection process
for clinical trials and studies and maximise the number of high-quality trial-ready sites. It …

We believe there are issues of concern over the governance of the UK’s largest private
pension, the Universities Superannuation Scheme (USS). The Trustees have a fiduciary duty to …